Candel Therapeutics
(NASDAQ) CADL
Candel Therapeutics Financials at a Glance
Market Cap
$366.23M
Revenue (TTM)
$0.00
Net Income (TTM)
$38.18M
EPS (TTM)
$-0.70
P/E Ratio
-7.13
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$5.01
Volume
36,230
Open
$4.85
Price
$5.01
Volume
36,230
Open
$4.85
Previous Close
$5.01
Daily Range
$4.84 - $5.10
52-Week Range
$4.25 - $7.25
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$5.01
Volume
36,230
Open
$4.85
Previous Close
$5.01
Daily Range
$4.84 - $5.10
52-Week Range
$4.25 - $7.25
CADL News
CADL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Candel Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
55
CEO
Paul-Peter Tak, MD, PhD
Website
www.candeltx.comHeadquarters
Needham, MA 02494, US
CADL Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-65%
Return on Capital
-42%
Return on Assets
-30%
Earnings Yield
-14.03%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$366.23M
Shares Outstanding
73.25M
Volume
36.23K
Short Interest
0.00%
Avg. Volume
1.12M
Financials (TTM)
Gross Profit
$845.00K
Operating Income
$48.27M
EBITDA
$47.42M
Operating Cash Flow
$38.31M
Capital Expenditure
$587.00K
Free Cash Flow
$38.90M
Cash & ST Invst.
$119.73M
Total Debt
$1.90M
Candel Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$163.00K
+33.5%
Gross Margin
0.00%
N/A
Market Cap
$366.23M
N/A
Market Cap/Employee
$9.64M
N/A
Employees
38
N/A
Net Income
$29.50M
-109.6%
EBITDA
$40.12M
-198.6%
Quarterly Fundamentals
Net Cash
$117.83M
+32.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$1.46M
-51.5%
Short Term Debt
$445.00K
-95.7%
Return on Assets
-30.50%
N/A
Return on Invested Capital
-41.54%
N/A
Free Cash Flow
$10.98M
-88.7%
Operating Cash Flow
$10.57M
-81.8%